Drug Trial Radar · NCT00789750
Colesevelam as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Last checked: Nov 19, 2026Latest source record: Jun 26, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
562
Actual
Start
Apr 2009
Primary completion
Jul 2012
Study completion Jul 2012
Sponsor
- Lead sponsor
- Daiichi SankyoDaiichi Sankyo (DSNKY)
- Sponsor type
- Industry
- First posted
- Nov 13, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The current study investigates colesevelam as add-on therapy to pioglitazone to improve glycemic control in subjects with type 2 diabetes mellitus not adequately controlled with pioglitazone monotherapy or pioglitazone in combination with either metformin or a sulfonylurea. The study will evaluate if colesevelam add-on to pioglitazone therapy for type 2 diabetes mellitus will be safe, well tolerated, and efficacious.
Conditions
- Type 2 Diabetes Mellitus
Interventions
ColesevelamDrug
Colesevelam 625 mg tablets
PlaceboDrug
Placebo tablets appearing to be colesevelam
PioglitazoneDrug
30 mg or 45 mg pioglitazone therapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Hemoglobin A1c (HbA1c) at Week 24Time frame: Baseline, Week 24
Locations
141 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Birmingham, Alabama
Site not named
Birmingham, Alabama
Site not named
Birmingham, Alabama
Site not named
Montgomery, Alabama
Site not named
Montgomery, Alabama
Site not named
Green Valley, Arizona
Site not named
Mesa, Arizona
Site not named
Phoenix, Arizona
Site not named
Tempe, Arizona
Site not named
Tempe, Arizona
Site not named
Searcy, Arkansas
Site not named
Buena Park, California
Site not named
Burbank, California
Site not named
Chino, California
Site not named
Garden Grove, California
Site not named
Huntington Park, California
Site not named
La Mirada, California
Site not named
Lincoln, California
Site not named
Lomita, California
Site not named
Los Gatos, California
Site not named
Modesto, California
Site not named
San Diego, California
Site not named
Santa Ana, California
Site not named
Tustin, California
Site not named
Walnut Creek, California
Site not named
Coral Gables, Florida
Site not named
DeLand, Florida
Site not named
Delray Beach, Florida
Site not named
Gulf Breeze, Florida
Site not named
Hialeah, Florida
Site not named
Jacksonville, Florida
Site not named
Kissimmee, Florida
Site not named
Miami, Florida
Site not named
Miami, Florida
Site not named
Miami, Florida
Site not named
Miami, Florida
Site not named
Miami, Florida
Site not named
New Port Richey, Florida
Site not named
Ocala, Florida
Site not named
Ormond Beach, Florida
Showing 40 of 141 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.